N-Terminomic Changes in Neurons During Excitotoxicity Reveal Proteolytic Events Associated With Synaptic Dysfunctions and Potential Targets for Neuroprotection.

CRMP2 CaM kinase IIa CaM kinase IIb Src calpains excitotoxicity neuronal death neuroprotection proteolytic processing synaptic damage

Journal

Molecular & cellular proteomics : MCP
ISSN: 1535-9484
Titre abrégé: Mol Cell Proteomics
Pays: United States
ID NLM: 101125647

Informations de publication

Date de publication:
05 2023
Historique:
received: 07 07 2022
revised: 23 02 2023
accepted: 04 04 2023
medline: 26 5 2023
pubmed: 9 4 2023
entrez: 8 4 2023
Statut: ppublish

Résumé

Excitotoxicity, a neuronal death process in neurological disorders such as stroke, is initiated by the overstimulation of ionotropic glutamate receptors. Although dysregulation of proteolytic signaling networks is critical for excitotoxicity, the identity of affected proteins and mechanisms by which they induce neuronal cell death remain unclear. To address this, we used quantitative N-terminomics to identify proteins modified by proteolysis in neurons undergoing excitotoxic cell death. We found that most proteolytically processed proteins in excitotoxic neurons are likely substrates of calpains, including key synaptic regulatory proteins such as CRMP2, doublecortin-like kinase I, Src tyrosine kinase and calmodulin-dependent protein kinase IIβ (CaMKIIβ). Critically, calpain-catalyzed proteolytic processing of these proteins generates stable truncated fragments with altered activities that potentially contribute to neuronal death by perturbing synaptic organization and function. Blocking calpain-mediated proteolysis of one of these proteins, Src, protected against neuronal loss in a rat model of neurotoxicity. Extrapolation of our N-terminomic results led to the discovery that CaMKIIα, an isoform of CaMKIIβ, undergoes differential processing in mouse brains under physiological conditions and during ischemic stroke. In summary, by identifying the neuronal proteins undergoing proteolysis during excitotoxicity, our findings offer new insights into excitotoxic neuronal death mechanisms and reveal potential neuroprotective targets for neurological disorders.

Identifiants

pubmed: 37030595
pii: S1535-9476(23)00053-1
doi: 10.1016/j.mcpro.2023.100543
pmc: PMC10199228
pii:
doi:

Substances chimiques

Calpain EC 3.4.22.-
Glutamic Acid 3KX376GY7L

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

100543

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest The authors declare no competing interest.

Auteurs

S Sadia Ameen (SS)

Department of Biochemistry and Pharmacology, University of Melbourne, Parkville, Victoria, Australia; Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria, Australia.

Nane Griem-Krey (N)

Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Antoine Dufour (A)

Department of Physiology and Pharmacology, University of Calgary, Calgary, Alberta, Canada.

M Iqbal Hossain (MI)

Department of Biochemistry and Pharmacology, University of Melbourne, Parkville, Victoria, Australia; Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria, Australia; Department of Pharmacology and Toxicology, University of Alabama, Birmingham, Alabama, USA.

Ashfaqul Hoque (A)

St Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia.

Sharelle Sturgeon (S)

Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia.

Harshal Nandurkar (H)

Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia.

Dominik F Draxler (DF)

Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia.

Robert L Medcalf (RL)

Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia.

Mohd Aizuddin Kamaruddin (MA)

Department of Biochemistry and Pharmacology, University of Melbourne, Parkville, Victoria, Australia; Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria, Australia.

Isabelle S Lucet (IS)

Chemical Biology Division, The Walter and Eliza Hall Institute for Medical Research, Parkville, Victoria, Australia; Department of Medical Biology, University of Melbourne, Parkville, Victoria, Australia.

Michael G Leeming (MG)

Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria, Australia.

Dazhi Liu (D)

Department of Neurology, School of Medicine, University of California, Davis, California, USA.

Amardeep Dhillon (A)

Faculty of Health, Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Waurn Ponds, Victoria, Australia.

Jet Phey Lim (JP)

Faculty of Health, Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Waurn Ponds, Victoria, Australia.

Faiza Basheer (F)

Faculty of Health, Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Waurn Ponds, Victoria, Australia.

Hong-Jian Zhu (HJ)

Department of Surgery (Royal Melbourne Hospital), University of Melbourne, Parkville, Victoria, Australia.

Laita Bokhari (L)

Department of Biochemistry and Pharmacology, University of Melbourne, Parkville, Victoria, Australia; Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria, Australia.

Carli L Roulston (CL)

Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australia.

Prasad N Paradkar (PN)

CSIRO Health & Biosecurity, Australian Centre for Disease Preparedness, East Geelong, Victoria, Australia.

Oded Kleifeld (O)

Faculty of Biology, Technion-Israel Institute of Technology, Technion City, Haifa, Israel.

Andrew N Clarkson (AN)

Department of Anatomy, Brain Health Research Centre and Brain Research New Zealand, University of Otago, Dunedin, New Zealand.

Petrine Wellendorph (P)

Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Giuseppe D Ciccotosto (GD)

Department of Biochemistry and Pharmacology, University of Melbourne, Parkville, Victoria, Australia; Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria, Australia. Electronic address: j.ciccotosto@unimelb.edu.au.

Nicholas A Williamson (NA)

Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria, Australia. Electronic address: nawill@unimelb.edu.au.

Ching-Seng Ang (CS)

Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria, Australia. Electronic address: ching-seng.ang@unimelb.edu.au.

Heung-Chin Cheng (HC)

Department of Biochemistry and Pharmacology, University of Melbourne, Parkville, Victoria, Australia; Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria, Australia. Electronic address: heung@unimelb.edu.au.

Articles similaires

Humans Child Nervous System Diseases Adolescent Polypharmacy
Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice

Classifications MeSH